Активы Изменить Дата
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Akebia Therapeutics USD 342.13M 7.53M 2026-09
Almirall EUR 2.37B 29.97M 2026-06
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amarin USD 634.08M 9.72M 2026-09
Ardelyx USD 587.52M 11.63M 2026-09
Astellas Pharma JPY 3.53T 164.74B 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
Incyte USD 7.29B 585.39M 2026-09
Ironwood Pharmaceuticals USD 290.59M 5.46M 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 318.68M 26.72M 2026-09
Moderna USD 13.47B 2.51B 2026-09
Myriad Genetics USD 638.9M 34.8M 2026-06
Pacira USD 34.68B 33.44B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Takeda JPY 15.27T 391.77B 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12